Erin Angelini

Erin Angelini

Auto-generated profile, based on publicly available information

Erin Angelini

Allen Institute, Cell Science; Seattle, WA, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2022 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
EAErin Angelini
Erin Angelini
YWYue Wang
Yue Wang
JZJoseph Xu Zhou
Joseph Xu Zhou
Hong QianHong Qian
Hong Qian
SHSui Huang
Sui Huang
Intratumor cellular heterogeneity and non-genetic cell plasticity in tumors pose a recently recognized challenge to cancer treatment. Because of the dispersion of initial cell states within a clonal tumor cell population, a perturbation imparted by a cytocidal drug only kills a fraction of cells. Due to dynamic instability of cellular states the cells not killed are pushed by the treatment into a variety of functional states, including a “stem-like state” that confers resistance to treatment and regenerative capacity. This immanent stress-induced stemness competes against cell death in response to the same perturbation and may explain the near-inevitable recurrence after any treatment. This double-edged-sword mechanism of treatment complements the selection of preexisting resistant cells in explaining post-treatment progression. Unlike selection, the induction of a resistant state has not been systematically analyzed as an immanent cause of relapse. Here, we present a generic elementary model and analytical examination of this intrinsic limitation to therapy. We show how the relative proclivity towards cell death versus transition into a stem-like state, as a function of drug dose, establishes either a window of opportunity for containing tumors or the inevitability of progression following therapy. The model considers measurable cell behaviors independent of specific molecular pathways and provides a new theoretical framework for optimizing therapy dosing and scheduling as cancer treatment paradigms move from “maximal tolerated dose,” which may promote therapy induced-stemness, to repeated “minimally effective doses” (as in adaptive therapies), which contain the tumor and avoid therapy-induced progression.

12 March 2023 in The Journal of Physical Chemistry B
Verified
Journal Article
Closed access
EAErin Angelini
Erin Angelini
Hong QianHong Qian
Hong Qian

7 October 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
EAErin Angelini
Erin Angelini
YWYue Wang
Yue Wang
JZJoseph X. Zhou
Joseph X. Zhou
Hong QianHong Qian
Hong Qian
SHSui Huang
Sui Huang
A bstract: Intratumor cellular heterogeneity and non-genetic cell plasticity in tumors pose a recently recognized challenge to cancer treatment. Because of the dispersion of initial cell states within a clonal tumor cell population, a perturbation imparted by a cytocidal drug only kills a fraction of cells. Due to dynamic instability of cellular states the cells not killed are pushed by the treatment into a variety of functional states, including a “stem-like state” that confers resistance to treatment and regenerative capacity. This immanent stress-induced stemness competes against cell death in response to the same perturbation and may explain the near-inevitable recurrence after any treatment. This double-edged-sword mechanism of treatment complements the selection of preexisting resistant cells in explaining post-treatment progression. Unlike selection, the induction of a resistant state has not been systematically analyzed as an immanent cause of relapse. Here, we present a generic elementary model and analytical examination of this intrinsic limitation to therapy. We show how the relative proclivity towards cell death versus transition into a stem-like state, as a function of drug dose, establishes either a window of opportunity for containing tumors or the inevitability of progression following therapy. The model considers measurable cell behaviors independent of specific molecular pathways and provides a new theoretical framework for optimizing therapy dosing and scheduling as cancer treatment paradigms move from “maximal tolerated dose,” which may promote therapy induced-stemness, to repeated “minimally effective doses” (as in adaptive therapies), which contain the tumor and avoid therapy-induced progression.

11 July 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
EAErin Angelini
Erin Angelini
CLChantelle L. Leveille
Chantelle L. Leveille
SPSerge E. Parent
Serge E. Parent
RZRebecca J. Zaunbrecher
Rebecca J. Zaunbrecher
TBTiffany Barszczewski
Tiffany Barszczewski
MVMatheus P. Viana
Matheus P. Viana
Cell states are increasingly conceptualized as attractors of high-dimensional dynamical systems, yet quantitative approaches for integrating phenotypic information into this framework remain limited. Here, we take an image-based approach that combines unsupervised machine learning (ML) with timelapse imaging to extract and characterize the temporal dynamics of morphological features. Using a cell line with endogenously tagged VE-cadherin, we acquired brightfield and fluorescence timelapse images of human induced pluripotent stem cell-derived endothelial cell (hiPSC-EC) monolayers, which adopt distinct phenotypes at two different magnitudes of shear stress in terms of their morphology, behavior, and VE-cadherin organization. To quantify these phenotypic cell states without segmentation, we trained a diffusion autoencoder to predict VE-cadherin signal from brightfield images. We identified interpretable ML-based features representing cell orientation, elongation, and local density. Treating these variables as dimensions of a morphological state space, we estimated a data-driven vector field and found that the two observed phenotypic cell states correspond to stable fixed points of the inferred dynamical system. Mapping measured cell migration coherence onto this space further distinguished the states. Imaging cells across intermediate shear stresses revealed a regime of bistability in which both states coexist, indicating that the shear-stress-dependent transition between endothelial cell states occurs as a bifurcation of the inferred dynamical system. Finally, we applied this method to study an N-terminal truncation of VE-cadherin, finding that mutated cells preserve alignment and coherent migration, but exhibit altered morphology and increased migration speed. This work demonstrates the applicability of a dynamical systems approach to quantitatively characterize morphological aspects of cell state from interpretable ML-based features.

23 July 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
EAErin Angelini
Erin Angelini
CLChantelle L. Leveille
Chantelle L. Leveille
SPSerge E. Parent
Serge E. Parent
RZRebecca J. Zaunbrecher
Rebecca J. Zaunbrecher
TBTiffany Barszczewski
Tiffany Barszczewski
MVMatheus Palhares Viana
Matheus Palhares Viana
There is increasing interest in quantitatively combining phenotypic information and existing mathematical frameworks for cell state dynamics. We used hiPSC-derived endothelial cells as a controllable model system that adopts two distinct phenotypes at different magnitudes of shear stress. We trained a diffusion autoencoder model on timelapse imaging data to extract interpretable morphological features from brightfield. In this feature space, we found that observed phenotypic states correspond to stable fixed points of an inferred dynamical system. Cell migration coherence at these stable fixed points further distinguishes the states. Imaging cells across intermediate shear stresses revealed a regime of bistability, indicating that the shear-stress-dependent cell state transition occurs as a bifurcation. In N-terminally truncated VE-cadherin-expressing cells, we found that orientation and coherent migration were preserved, but morphology and migration speed were not. We demonstrate how machine learning and dynamical systems can be used in tandem to quantitatively characterize phenotypic cell states.